Briana Contreras

Greg Baker, CEO of AffirmedRx, gave a presentation at the PBMI Annual National Conference where he talked about PBM trends and their impact on employers.

Women who experience ongoing trouble sleeping in midlife face a 70 to 75% increased risk of heart disease.

The CONVOKE study is investigating the effectiveness of the smartphone app as a therapy for negative symptoms of schizophrenia among adults.

Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.

Despite its aim to reduce in-person visits, a virtual urgent care (VUC) program in Ontario, Canada found that patients seen by a VUC provider with no further referral were more likely to visit the emergency room than those who came directly to the department.

Authors of a platinum-ranked poster presented at AMCP Nexus 2023 suggested that the burden of increased spending on specialty medications varies by race and wage among employees with employer-sponsored health insurance.

A study published in the Lancet found that patients who had previously tested positive for COVID-19 had lower cognitive accuracy compared to negative controls.

Although wastewater data and COVID case/hospitalization rates no longer accurately reflect each other, researchers suggest wastewater surveillance may be the best metric for monitoring the amount of circulating virus.

The Protect Patient Access to Pharmacies Act will help to secure Medicare patients’ freedom to receive medications and care from the pharmacy of their choice.

The World Health Organization (WHO) shared their enthusiasm for the “appropriate” use of new technologies, and urged safety and caution as automation becomes normalized in the health care sphere.

The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.

Researchers of a new study investigated what's causing vaccine hesitancy, and why individuals are feeling vaccine fatigue.

The ruling states that insurers and employers who run plans for employees will have a choice over how- and whether- to cover certain routine screenings, exams and tests.

The World Health Organization (WHO) and the CDC recommend different doses when it comes to vaccine protection against the human papillomavirus (HPV).

The 2022 Virtual Care Survey Report from Summus has determined that many healthcare users have responded positively to virtual care services, as they would like to see more out of such offerings.

As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.

Though, unvaccinated people are at much greater risk for severe outcomes than folks the same age who are caught up on boosters.

Researchers at Cleveland Clinic evaluated whether a bivalent COVID-19 vaccine protects against both strains of the virus - the original virus strain and a component of the omicron variant.

Dr. Syra Madad of the NYC hospital system and an Infectious Disease Epidemiologist at Harvard's Belfer Center for Science and International Affairs responded to Dr. Anthony Fauci's, director of NIAID, statement made in late November that the U.S. is “certainly” still in the middle of a Covid-19 pandemic.

A recent study shows teenagers' mental health and brain maturation increased due to the effects of the COVID-19 pandemic.

Less than half (45%) of all nursing facility residents and less than a quarter of staff (22%) are up to date with their COVID-19 vaccinations. That is a sharp drop from the 87% of nursing facility residents and staff who completed their primary vaccination series.

Although initial infection of the virus has resulted in risk of hospitalization and mortality, researchers looked into the effects of reinfection as data has been unclear.

Improvement of vitiligo repigmentation in patients can result in higher Vitiligo Noticeability Scale values when assessed from patient-reported outcome measures versus traditional investigator-assessed studies.

Non-hospitalized symptomatic COVID-19 patients who were treated with ciclesonide to alleviate early symptoms did not see any difference in results compared to patients who were treated with a placebo of the drug.